The administration of CIB-6 resulted in significantly reduced tumor burdens in the SK-HEP-1 subcutaneous xenograft mice relative to their vehicle-treated and IFN-α-treated counterparts (Figure 6A,B). Here, IFNA1 is linked to neoplasm.